|
|
Thursday, March 10, 2005
|
|
| |
Bad Trade at Biogen IDEC. An executive resigns as regulators look into a stock sale. [The Motley Fool]
Interesting. This refers to Martha Stewart as a reason not to
insider trade on biotech stocks. I would think that on the whole,
Martha Stewart's experience looks like a pretty low price to pay for $6
million dollars worth of stock that you know is going to tank in a few
days.
4:25:44 PM 
|
|
|
|
© Copyright
2005
Judy Smith.
Last update:
4/22/2005; 5:19:24 PM.
|
|
|
